Our clinical pharmacists can discuss formulation options, offer clinical insights, deliver educational seminars, and collaborate with your team to expand treatment options for your patients
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases
Future Research Directions and Unanswered Questions Despite 50+ years since Pickarts initial isolation work, significant mechanistic and clinical questions remain: Receptor identity: GHK-Cus gene regulatory effects are well-documented, but the specific cellular receptors mediating them remain incompletely characterized
Metformins effects are mediated through AMPK, insulin, and adipocytokine signaling, that influence key Alzheimers-related processes
Every injection that leaks, absorbs poorly, or hits muscle instead of fat represents lost money and lost results
In recent years there has been considerable interest in the therapeutic potential of l-carnitine and its acetylated derivative acetyl-l-carnitine (ALCAR) for neuroprotection in a number of disorders including hypoxia-ischemia, traumatic brain injury, Alzheimers disease and in conditions leading to central or peripheral nervous system injury